George Tziras
Fortune : 452 490 $ au 31/08/2026
Fortune : 452 490 $ au 31/08/2026
George Tziras is currently Chief Executive Officer & Director at Small Pharma, Inc. since 2022, Non-Executive Director at Cybin UK Ltd. since 2015, and Chief Business Officer at Cybin, Inc. starting in 2025.
Formerly, Mr. Tziras was Chief Business Officer & Director at Unilock Capital Corp.
Education includes undergraduate studies at the University of Oxford and graduate studies at The Paul H.
Nitze School of Advanced International Studies.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYBIN, INC. 0,06% | 02/09/2026 | 38 477 ( 0,06% ) | 452 490 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SMALL PHARMA INC. | Directeur Général | 20/07/2022 |
| CYBIN INC. | Investor Relations Contact | - |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Directeur/Membre du Conseil | 01/01/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
| SMALL PHARMA INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national